Literature DB >> 25515034

Hypovitaminosis D is associated with endothelial dysfunction in patients with non-dialysis chronic kidney disease.

Qing-Yan Zhang1, Chun-Ming Jiang, Cheng Sun, Tian-Feng Tang, Bo Jin, Dong-Wei Cao, Jing-Song He, Miao Zhang.   

Abstract

OBJECTIVE: Cardiovascular events are highly prevalent in chronic kidney disease (CKD). Hypovitaminosis D and vascular endothelial dysfunction are risk factors for cardiovascular morbidity and mortality and they both are common in CKD patients. This study aimed to investigate the association between hypovitaminosis D and endothelial dysfunction in non-dialysis CKD patients.
METHODS: In 117 non-dialysis CKD patients, we assessed endothelial function by brachial artery flow-mediated dilation (FMD), soluble vascular cell adhesion molecule-1 (sVCAM-1) and sE-selectin. 25-hydroxyvitamin D [25(OH)D] was measured by electrochemiluminescence immunoassay.
RESULTS: Brachial artery FMD was lower in vitamin D-deficient and -insufficient versus vitamin D-sufficient groups, with the lowest value observed in the vitamin D-deficient group. Conversely, sVCAM-1 and sE-selectin were higher in vitamin D-deficient and -insufficient groups versus vitamin D-sufficient, and the highest value was observed in the vitamin D-deficient group. There was a positive association between FMD and 25(OH)D (r = 0.556, p < 0.001) and negative correlations between both sVCAM-1 (r = -0.549, p < 0.001) and sE-selectin (r = -0.360, p < 0.001) and 25(OH)D. These associations remained significant after adjusting for confounders.
CONCLUSIONS: Hypovitaminosis D is associated with endothelial dysfunction in non-dialysis CKD patients. Further studies are needed to confirm whether vitamin D supplementation can improve endothelial function and reduce cardiovascular events in these patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25515034     DOI: 10.1007/s40620-014-0167-8

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  22 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

Review 3.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

Review 4.  Endothelial function and dysfunction: testing and clinical relevance.

Authors:  John E Deanfield; Julian P Halcox; Ton J Rabelink
Journal:  Circulation       Date:  2007-03-13       Impact factor: 29.690

5.  Cross-talk between the kidney and the cardiovascular system.

Authors:  Kerstin Amann; Christoph Wanner; Eberhard Ritz
Journal:  J Am Soc Nephrol       Date:  2006-07-06       Impact factor: 10.121

Review 6.  Endothelial dysfunction: a marker of atherosclerotic risk.

Authors:  Piero O Bonetti; Lilach O Lerman; Amir Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

7.  Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study.

Authors:  Ronald M A Henry; Piet J Kostense; Griët Bos; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Lex M Bouter; Coen D A Stehouwer
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

8.  Anti-inflammatory effect of 1alpha,25-dihydroxyvitamin D(3) in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki disease.

Authors:  Yasuo Suzuki; Takashi Ichiyama; Ayami Ohsaki; Shunji Hasegawa; Masahiro Shiraishi; Susumu Furukawa
Journal:  J Steroid Biochem Mol Biol       Date:  2008-12-24       Impact factor: 4.292

9.  Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial.

Authors:  Sakineh Shab-Bidar; Tirang R Neyestani; Abolghassem Djazayery; Mohammad-Reza Eshraghian; Anahita Houshiarrad; A'azam Gharavi; Ali Kalayi; Nastaran Shariatzadeh; Malihe Zahedirad; Niloufar Khalaji; Homa Haidari
Journal:  BMC Med       Date:  2011-11-24       Impact factor: 8.775

10.  Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients.

Authors:  Nihil Chitalia; Tuan Ismail; Laura Tooth; Frances Boa; Geeta Hampson; David Goldsmith; Juan Carlos Kaski; Debasish Banerjee
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more
  17 in total

1.  Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial.

Authors:  Juan C Ramirez-Sandoval; Mauricio Arvizu-Hernandez; Cristino Cruz; Barbara Vazquez-Cantu; Luis J Rojas-Concha; Luis Tamez; Fagundo Reynerio; F Enrique Gomez; Ricardo Correa-Rotter
Journal:  J Nephrol       Date:  2019-03-19       Impact factor: 3.902

2.  Vitamin D supplementation for the improvement of vascular function in patients with chronic kidney disease: a meta-analysis of randomized controlled trials.

Authors:  Ding Dou; Bing Yang; Hongqiao Gan; Dengpiao Xie; Huangwei Lei; Naijing Ye
Journal:  Int Urol Nephrol       Date:  2019-02-08       Impact factor: 2.370

3.  Effect of paricalcitol and enalapril on renal inflammation/oxidative stress in atherosclerosis.

Authors:  Kazim Husain; Edu Suarez; Angel Isidro; Wilfredo Hernandez; Leon Ferder
Journal:  World J Biol Chem       Date:  2015-08-26

Review 4.  Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology.

Authors:  Luigi Francesco Morrone; Pergiorgio Bolasco; Corrado Camerini; Giuseppe Cianciolo; Adamasco Cupisti; Andrea Galassi; Sandro Mazzaferro; Domenico Russo; Luigi Russo; Mario Cozzolino
Journal:  J Nephrol       Date:  2016-04-09       Impact factor: 3.902

5.  Vitamin D supplementation improves endothelial dysfunction in patients with non-dialysis chronic kidney disease.

Authors:  Qingyan Zhang; Miao Zhang; Hengjin Wang; Cheng Sun; Yuan Feng; Wei Zhu; Dongwei Cao; Qiuyuan Shao; Nan Li; Yangyang Xia; Tianfeng Tang; Cheng Wan; Jing Liu; Bo Jin; Min Zhao; Chunming Jiang
Journal:  Int Urol Nephrol       Date:  2018-02-26       Impact factor: 2.370

6.  A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD.

Authors:  Vivek Kumar; Ashok Kumar Yadav; Anupam Lal; Vinod Kumar; Manphool Singhal; Laurent Billot; Krishan Lal Gupta; Debasish Banerjee; Vivekanand Jha
Journal:  J Am Soc Nephrol       Date:  2017-06-30       Impact factor: 10.121

7.  Vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5.

Authors:  César Augusto Restrepo Valencia; José Vicente Aguirre Arango
Journal:  Colomb Med (Cali)       Date:  2016-09-30

Review 8.  Vitamin D and Hypertension.

Authors:  Hye Yun Jeong; Kyung Mi Park; Mi Jung Lee; Dong Ho Yang; Sang Hoon Kim; So-Young Lee
Journal:  Electrolyte Blood Press       Date:  2017-09-30

Review 9.  Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice.

Authors:  Carlo Alfieri; Oksana Ruzhytska; Simone Vettoretti; Lara Caldiroli; Mario Cozzolino; Piergiorgio Messa
Journal:  Nutrients       Date:  2019-08-15       Impact factor: 5.717

Review 10.  Role of Vitamin D Status in Diabetic Patients with Renal Disease.

Authors:  Guido Gembillo; Valeria Cernaro; Antonino Salvo; Rossella Siligato; Alfredo Laudani; Michele Buemi; Domenico Santoro
Journal:  Medicina (Kaunas)       Date:  2019-06-13       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.